Literature DB >> 21248742

HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia.

Simon C Warby1, Henk Visscher, Jennifer A Collins, Crystal N Doty, Catherine Carter, Stefanie L Butland, Anna R Hayden, Ichiro Kanazawa, Colin J Ross, Michael R Hayden.   

Abstract

Huntington disease (HD) results from CAG expansion in the huntingtin (HTT) gene. Although HD occurs worldwide, there are large geographic differences in its prevalence. The prevalence in populations derived from Europe is 10-100 times greater than in East Asia. The European general population chromosomes can be grouped into three major haplogroups (group of similar haplotypes): A, B and C. The majority of HD chromosomes in Europe are found on haplogroup A. However, in the East-Asian populations of China and Japan, we find the majority of HD chromosomes are associated with haplogroup C. The highest risk HD haplotypes (A1 and A2), are absent from the general and HD populations of China and Japan, and therefore provide an explanation for why HD prevalence is low in East Asia. Interestingly, both East-Asian and European populations share a similar low level of HD on haplogroup C. Our data are consistent with the hypothesis that different HTT haplotypes have different mutation rates, and geographic differences in HTT haplotypes explain the difference in HD prevalence. Further, the bias for expansion on haplogroup C in the East-Asian population cannot be explained by a higher average CAG size, as haplogroup C has a lower average CAG size in the general East-Asian population compared with other haplogroups. This finding suggests that CAG-tract size is not the only factor important for CAG instability. Instead, the expansion bias may be because of genetic cis-elements within the haplotype that influence CAG instability in HTT, possibly through different mutational mechanisms for the different haplogroups.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21248742      PMCID: PMC3083615          DOI: 10.1038/ejhg.2010.229

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  44 in total

1.  Inferring human population sizes, divergence times and rates of gene flow from mitochondrial, X and Y chromosome resequencing data.

Authors:  Daniel Garrigan; Sarah B Kingan; Maya M Pilkington; Jason A Wilder; Murray P Cox; Himla Soodyall; Beverly Strassmann; Giovanni Destro-Bisol; Peter de Knijff; Andrea Novelletto; Jonathan Friedlaender; Michael F Hammer
Journal:  Genetics       Date:  2007-12       Impact factor: 4.562

2.  The prevalence of Huntington's chorea in South Africa.

Authors:  M R Hayden; J M MacGregor; P H Beighton
Journal:  S Afr Med J       Date:  1980-08-02

3.  A common SNP haplotype provides molecular proof of a founder effect of Huntington disease linking two South African populations.

Authors:  Janine Scholefield; Jacquie Greenberg
Journal:  Eur J Hum Genet       Date:  2007-02-28       Impact factor: 4.246

4.  Family history and DNA analysis in patients with suspected Huntington's disease.

Authors:  S Siesling; M Vegter-van de Vlis; M Losekoot; R D Belfroid; J A Maat-Kievit; H P Kremer; R A Roos
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-07       Impact factor: 10.154

5.  Technical standards and guidelines for Huntington disease testing.

Authors:  Nicholas T Potter; Elaine B Spector; Thomas W Prior
Journal:  Genet Med       Date:  2004 Jan-Feb       Impact factor: 8.822

Review 6.  The epidemiology of Huntington's disease.

Authors:  P S Harper
Journal:  Hum Genet       Date:  1992-06       Impact factor: 4.132

7.  The frequency of inherited disorders database: prevalence of Huntington disease.

Authors:  L N Al-Jader; P S Harper; M Krawczak; S R Palmer
Journal:  Community Genet       Date:  2001

8.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

Authors:  D R Langbehn; R R Brinkman; D Falush; J S Paulsen; M R Hayden
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

9.  Dynamic mutation in Dutch Huntington's disease patients: increased paternal repeat instability extending to within the normal size range.

Authors:  K E De Rooij; P A De Koning Gans; M I Skraastad; R D Belfroid; M Vegter-Van Der Vlis; R A Roos; E Bakker; G J Van Ommen; J T Den Dunnen; M Losekoot
Journal:  J Med Genet       Date:  1993-12       Impact factor: 6.318

10.  CTCF cis-regulates trinucleotide repeat instability in an epigenetic manner: a novel basis for mutational hot spot determination.

Authors:  Randell T Libby; Katharine A Hagerman; Victor V Pineda; Rachel Lau; Diane H Cho; Sandy L Baccam; Michelle M Axford; John D Cleary; James M Moore; Bryce L Sopher; Stephen J Tapscott; Galina N Filippova; Christopher E Pearson; Albert R La Spada
Journal:  PLoS Genet       Date:  2008-11-14       Impact factor: 5.917

View more
  42 in total

1.  De novo Huntington disease caused by 26-44 CAG repeat expansion on a low-risk haplotype.

Authors:  Gunnar Houge; Ove Bruland; Inga Bjørnevoll; Michael R Hayden; Alicia Semaka
Journal:  Neurology       Date:  2013-08-14       Impact factor: 9.910

Review 2.  Modifiers of CAG/CTG Repeat Instability: Insights from Mammalian Models.

Authors:  Vanessa C Wheeler; Vincent Dion
Journal:  J Huntingtons Dis       Date:  2021

3.  A Comprehensive Haplotype-Targeting Strategy for Allele-Specific HTT Suppression in Huntington Disease.

Authors:  Chris Kay; Jennifer A Collins; Nicholas S Caron; Luciana de Andrade Agostinho; Hailey Findlay-Black; Lorenzo Casal; Dulika Sumathipala; Vajira H W Dissanayake; Mario Cornejo-Olivas; Fiona Baine; Amanda Krause; Jacquie L Greenberg; Carmen Lúcia Antão Paiva; Ferdinando Squitieri; Michael R Hayden
Journal:  Am J Hum Genet       Date:  2019-11-07       Impact factor: 11.025

Review 4.  Therapeutic approaches to Huntington disease: from the bench to the clinic.

Authors:  Nicholas S Caron; E Ray Dorsey; Michael R Hayden
Journal:  Nat Rev Drug Discov       Date:  2018-09-21       Impact factor: 84.694

5.  Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region.

Authors:  Jong-Min Lee; Tammy Gillis; Jayalakshmi Srinidhi Mysore; Eliana Marisa Ramos; Richard H Myers; Michael R Hayden; Patrick J Morrison; Martha Nance; Christopher A Ross; Russell L Margolis; Ferdinando Squitieri; Annamaria Griguoli; Stefano Di Donato; Estrella Gomez-Tortosa; Carmen Ayuso; Oksana Suchowersky; Ronald J Trent; Elizabeth McCusker; Andrea Novelletto; Marina Frontali; Randi Jones; Tetsuo Ashizawa; Samuel Frank; Marie-Helene Saint-Hilaire; Steven M Hersch; Herminia D Rosas; Diane Lucente; Madaline B Harrison; Andrea Zanko; Ruth K Abramson; Karen Marder; Jorge Sequeiros; Marcy E MacDonald; James F Gusella
Journal:  Am J Hum Genet       Date:  2012-03-01       Impact factor: 11.025

Review 6.  Palmitoylation and depalmitoylation defects.

Authors:  Thorsten Hornemann
Journal:  J Inherit Metab Dis       Date:  2014-08-05       Impact factor: 4.982

7.  Huntington disease among the Navajo: A population-based study in the Navajo Nation.

Authors:  Paul H Gordon; Jason M Mehal; Andrew S Rowland; James E Cheek; Michael L Bartholomew
Journal:  Neurology       Date:  2016-02-19       Impact factor: 9.910

8.  The targetable A1 Huntington disease haplotype has distinct Amerindian and European origins in Latin America.

Authors:  Chris Kay; Indira Tirado-Hurtado; Mario Cornejo-Olivas; Jennifer A Collins; Galen Wright; Miguel Inca-Martinez; Diego Veliz-Otani; Maria E Ketelaar; Ramy A Slama; Colin J Ross; Pilar Mazzetti; Michael R Hayden
Journal:  Eur J Hum Genet       Date:  2016-12-21       Impact factor: 4.246

9.  Haplotype-based stratification of Huntington's disease.

Authors:  Michael J Chao; Tammy Gillis; Ranjit S Atwal; Jayalakshmi Srinidhi Mysore; Jamshid Arjomand; Denise Harold; Peter Holmans; Lesley Jones; Michael Orth; Richard H Myers; Seung Kwak; Vanessa C Wheeler; Marcy E MacDonald; James F Gusella; Jong-Min Lee
Journal:  Eur J Hum Genet       Date:  2017-08-23       Impact factor: 4.246

Review 10.  Therapeutic approaches to preventing cell death in Huntington disease.

Authors:  Anna Kaplan; Brent R Stockwell
Journal:  Prog Neurobiol       Date:  2012-08-28       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.